When was SPR founded?

SPR was founded in 2008 and raised its 1st funding round within a year of its incorporation.

Where is SPR located?

SPR is headquartered in Cleveland, United States.

Who is the current CEO of SPR?

Maria Bennett of SPR. They have also founded 1 company.

How many employees does SPR have?

As of Sep 30, 2026, the latest employee count at SPR is 435.

Is SPR a funded company?

SPR is a funded company, having raised a total of $132M across 17 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 15, 2008.

When was the latest funding round of SPR?

SPR's latest funding was a $***** Grant (prize money) round on Mar 28, 2025, with participation from 1 investor. Its primary sector is Pain Management. In United States, the Pain Management sector has seen $61M in funding in 2026 to date.

Where does SPR rank among its competitors?

SPR ranks 1st amongst 54 active competitors, of which 4 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was SPR, which secured $5.99M in Mar, 2025.

Who are the top competitors of SPR?

SPR's top competitors include NeuraLace Medical, Remedee Labs and Neurometrix. Among them, SPR secured the most recent funding round in March, 2025.

SPR - 2026 Company Profile, Team, Funding & Competitors

Q: Is SPR an acquired company?

SPR got acquired by Medtronic on May 21, 2026.

Company Details

Developer of non-implant peripheral nerve stimulation systems for pain management. This company provides a clinically proven, patient-preferred non-surgical option for managing chronic, intractable, post-surgical, post-traumatic, and post-operative pain. The system offers symptomatic relief and is indicated for up to 60 days of use. The most common adverse events are skin irritation and erythema. The company is focused on advancing non-opioid, non-surgical, minimally invasive pain management solutions.

Website: sprpainrelief.com
Email ID: *****@sprpainrelief.com
Phone Number: +1 **********

Key Metrics

Founded Year

2008

Location

Cleveland, United States

Stage

Acquired

Total Funding

$132M in 17 rounds

Latest Funding Round

Grant (prize money), Mar 28, 2025, $*****

Investors

Revelation Partners & 14 more

Ranked

1^st among 54 active competitors

Employee Count

435 as on Sep 30, 2026

Similar Companies

NeuraLace Medical & 78 more

Exit Details

Acquired by Medtronic (May 21, 2026)

View SPR's full profile

SPR got acquired by Medtronic on May 21, 2026 at an acquisition amount of $*****.

Click here to take a look at SPR's acquisition in detail

SPR has raised a total funding of $132M over 17 rounds. Its first funding round was on Apr 15, 2008. Its latest funding round was a Grant (prize money) round on Mar 28, 2025 for $*****. 1 investor participated in its latest round. SPR has 15 institutional investors.

Here is the list of recent funding rounds of SPR:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 28, 2025	2002340	Grant (prize money)	4964311	8076934	2756705	4715002
Feb 01, 2024	8121643	Convertible Debt	9726862	3063018	7102162	2525515
Jan 30, 2024	8982338	Series D	2005277	1456750	Revelation Partners & 2 more	4507788

Access funding benchmarks and valuations. Sign up today!

View details of SPR's funding rounds and investors

The founders of SPR is Maria Bennett. Maria Bennett is the CEO of SPR.

Here are the details of SPR's key team members:

Maria Bennett: Founder & CEO of SPR.

View details of SPR's Founder profiles and Board Members

SPR's employee count trend

SPR has 435 employees as of Sep 26. Here is SPR's employee count trend over the years:

Uncover SPR's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SPR include NeuraLace Medical, Remedee Labs and Neurometrix. Here is the list of Top 10 competitors of SPR, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SPR 2008, Cleveland (United States), Acquired	Developer of non-implant peripheral nerve stimulation systems for pain management	$132M	Revelation Partners, BNSG Capital & 13 others	58/100
2nd	NeuraLace Medical 2016, San Diego (United States), Seed	Non-invasive neuromodulation for chronic neuropathic pain relief and improved patient outcomes	$5.85M	FusionX Ventures, BioBrit & 7 others	42/100
3rd	Remedee Labs 2016, Meylan (France), Series A	Developer of endorphin stimulation therapy for pain management	$27.8M	HCVC, Generali & 7 others	41/100
4th	Neurometrix 1996, Woburn (United States), Acquired	Developer of non-invasive medical devices for pain and neurological disorders	$14.6M	Deerfield, MIT & 8 others	38/100
5th	iTENS 1999, Akron (United States), Unfunded	Wireless pain relief device merging technology with TENS therapy	-	-	38/100
6th	Electromedical Technologies 2007, Phoenix (United States), Public	An electrotherapy device that helps reduce and eliminate chronic or acute pain	$105K	Yorkville Advisors	36/100
7th	Hollywog 2009, Chattanooga (United States), Unfunded	Pain relief solutions: TENS units, gel pads, and accessories	-	-	36/100
8th	Sublimed 2015, Moirans (France), Series A	Developer of pain management devices	$4.58M	Investisseur Prive, Kreaxi & 3 others	35/100
9th	Parasym 2015, London (United Kingdom), Unfunded	Provider of neurostimulation device	-	-	35/100
10th	Terapio 2005, Austin (United States), Series A	Medical devices providing TENS therapy for pain relief and muscle stimulation	$9.9M	Sante Ventures, Austin Technology Incubator ... & 4 others	34/100